Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for Oral Commissure Ptosis
NCT07646886Phase 4Not yet recruiting
- Sponsor
- Peking University
- Start
- Jul 2026
- Primary completion
- Jun 2027
01
Overview
Phase 4, randomised, single-blind trial of botulinum toxin type A in Oral commissure ptosis (2 arms), sponsored by Peking University. Primary endpoint: Improvement of Bilateral Oral Commissure Ptosis Angle from Baseline at 1 month. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Oral commissure ptosis
Beyond the preview
Go deeper on NCT07646886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07646886.